Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

المؤلفون: Wanner, Christoph¹ (AUTHOR) ; Cooper, Mark E² (AUTHOR); Johansen, Odd Erik³ (AUTHOR); Toto, Robert⁴ (AUTHOR); Rosenstock, Julio⁵ (AUTHOR); McGuire, Darren K⁴ (AUTHOR); Kahn, Steven E⁶ (AUTHOR); Pfarr, Egon⁷ (AUTHOR); Schnaidt, Sven⁸ (AUTHOR); Eynatten, Maximilian von⁷ (AUTHOR); George, Jyothis T⁷ (AUTHOR); Gollop, Nicholas D⁹ (AUTHOR); Marx, Nikolaus¹⁰ (AUTHOR); Alexander, John H¹¹ (AUTHOR); Zinman, Bernard^12,13 (AUTHOR); Perkovic, Vlado¹⁴ (AUTHOR); investigators, the CARMELINA (AUTHOR)
المصدر:
Clinical Kidney Journal. Jan2021, Vol. 14, p226-236. 11p.